Loading company…
Rewind Therapeutics develops advanced biotherapeutics for unmet medical needs, with a focus on oncology and neurodegenerative diseases.
Founded in Leuven, Belgium, Rewind Therapeutics develops biotherapeutics aimed at specific disease mechanisms, with emphasis on oncology and neurodegenerative diseases. Its Series A round raised EUR 15.20 mn from investors including Boehringer Ingelheim Venture and K.U. Leuven Research and Development, with the latest deal on January 25, 2023. The company plans to advance its lead program into clinical development and expand its drug pipeline. It is at the Series A stage.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in